Literature DB >> 2521504

Patterns of left ventricular dilation during the six months after myocardial infarction.

R W Jeremy1, K C Allman, G Bautovitch, P J Harris.   

Abstract

Changes in left ventricular volume after a first myocardial infarction were studied in 50 patients. Serial radionuclide angiograms were obtained 48 h, 10 days and 1 and 6 months after infarction and left ventricular volume measured by a nongeometric method. Left ventricular dilation (greater than or equal to 20% increase in end-diastolic volume) occurred within 10 days of infarction in 11 patients, who had a mean volume increase of 34 +/- 15% (p = 0.002 versus 48 h) at 10 days and 61 +/- 43% (p = 0.01 versus 10 days) at 6 months. Ten other patients manifested left ventricular dilation between 10 days and 6 months with a lesser volume increase of 42 +/- 18% by 6 months. Among the 21 patients with ventricular dilation, progressive dilation (serial volume increases greater than or equal to 20% on two or more occasions) occurred in 8 patients, who all had a large anterior infarct. Mean volume increases at 10 days and 1 and 6 months were 27 +/- 20%, 49 +/- 40% (p = 0.03 versus 10 days) and 79 +/- 37% (p = 0.006 versus 1 month), respectively, in this group. In patients with progressive dilation, left ventricular ejection fraction decreased from 35 +/- 6% at 48 h to 24 +/- 10% at 1 month (p less than 0.001) and 27 +/- 10% (p = 0.006) at 6 months. Between 1 month and 2 years after infarction six patients died, of whom four had progressive dilation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1989        PMID: 2521504     DOI: 10.1016/0735-1097(89)90503-2

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  20 in total

Review 1.  Advances in the medical management of acute coronary syndromes.

Authors:  C P Cannon
Journal:  J Thromb Thrombolysis       Date:  1999-04       Impact factor: 2.300

2.  Ventricular dilatation in the absence of ACE inhibitors: influence of haemodynamic and neurohormonal variables following myocardial infarction.

Authors:  J T Walsh; P D Batin; M Hawkins; D McEntegart; A J Cowley
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

3.  Ventricular remodelling after myocardial infarction.

Authors:  M A Vannan; D J Taylor
Journal:  Br Heart J       Date:  1992-09

4.  Assessment of left ventricular volumes and function by cine-MR imaging depending on the investigator's experience.

Authors:  A Bailly; J Lipiecki; P Chabrot; A Alfidja; J M Garcier; S Ughetto; J Ponsonnaille; L Boyer
Journal:  Surg Radiol Anat       Date:  2008-10-08       Impact factor: 1.246

Review 5.  Coronary artery disease, valvular heart disease, bradycardia, and heart failure.

Authors:  E Smith; H Powell; I R Hastie
Journal:  Postgrad Med J       Date:  1995-06       Impact factor: 2.401

Review 6.  Infarct restraint to limit adverse ventricular remodeling.

Authors:  Robert C Gorman; Benjamin M Jackson; Jason A Burdick; Joseph H Gorman
Journal:  J Cardiovasc Transl Res       Date:  2010-12-15       Impact factor: 4.132

7.  A novel method for quantifying the in-vivo mechanical effect of material injected into a myocardial infarction.

Authors:  Jonathan F Wenk; Parastou Eslami; Zhihong Zhang; Chun Xu; Ellen Kuhl; Joseph H Gorman; J Daniel Robb; Mark B Ratcliffe; Robert C Gorman; Julius M Guccione
Journal:  Ann Thorac Surg       Date:  2011-09       Impact factor: 4.330

8.  Impact of converting enzyme inhibition on progression of chronic heart failure: results of the Munich Mild Heart Failure Trial.

Authors:  F X Kleber; L Niemöller; W Doering
Journal:  Br Heart J       Date:  1992-04

9.  Early treatment with captopril after acute myocardial infarction.

Authors:  S G Ray; M Pye; K G Oldroyd; J Christie; D T Connelly; D B Northridge; I Ford; J J Morton; H J Dargie; S M Cobbe
Journal:  Br Heart J       Date:  1993-03

Review 10.  Post-myocardial infarction ventricular remodeling: animal and human studies.

Authors:  D E Vaughan; M A Pfeffer
Journal:  Cardiovasc Drugs Ther       Date:  1994-06       Impact factor: 3.727

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.